Moving Biotech Enrolls First Patient in Phase 2a Trial of 4P004, a Potential First-in-Class GLP-1 Therapy for Knee Osteoarthritis.

US biotech Genascence today announced the US Food and Drug Administration (FDA) has granted the Regenerative Medicine Advanced Therapy (RMAT) designation to GNSC-001, a potential first-in-class gene ...

Nanochon, a Washington, DC and Baltimore, MD-based orthopedic device biotech company developing an implant for treating ...

The knee is the largest joint on the body and most prone to issues like injury. A puffy, stiff, or painful knee can limit ...

Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...

As you all know, our gym trains people of all ages, but caters to the older population. It’s common to observe our elders ...